Find a Clinical Trial
Filter
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer
Breast cancer
All genders
16+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Squamous cell carcinoma
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
EA3191
Head and neck cancer
All genders
18-79
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
EAQ202
Cancer
All genders
18-39
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Remodel-2
Multiple sclerosis
All genders
18-55
Recruiting now
Department of Neurology
Lung CA Dental
Non-small cell lung cancer
All genders
45+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
HER2 Negative Breast Cancer
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA)
Fallopian tube cancer, Ovarian cancer, Peritoneal cancer
All genders
18+
Recruiting now
Cancer Center
Multi-spectral imaging
Ovarian cancer
Female
18-99
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center